메뉴 건너뛰기




Volumn , Issue , 2010, Pages 6434-6439

Advertising on Preferred Reporting Items for Patient-Reported Outcome instrument development: The PRIPROID

Author keywords

Development; Instrument; Measurement; Patient reported outcome; PRIPROID; Quality of life; Questionnaire

Indexed keywords

DEVELOPMENT; PATIENT REPORTED OUTCOME; PRIPROID; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 79951996055     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/ICISE.2010.5690274     Document Type: Conference Paper
Times cited : (1)

References (6)
  • 1
    • 0036112505 scopus 로고    scopus 로고
    • Assessing health status and quality-of-life instruments: Attributes and review criteria
    • Scientific Advisory Committee of the Medical Outcomes Trust, May
    • Scientific Advisory Committee of the Medical Outcomes Trust, Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res, Vol 11, pp.193-205, May 2002.
    • (2002) Qual Life Res , vol.11 , pp. 193-205
  • 2
    • 42749098792 scopus 로고    scopus 로고
    • Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance
    • U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, and U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health, October
    • U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, and U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health, Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes, Vol 4:79, October 2006.
    • (2006) Health Qual Life Outcomes , vol.4 , pp. 79
  • 3
    • 33746261692 scopus 로고    scopus 로고
    • U.S.Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research(CDER), Center for Biologics Evaluation and Research(CBER), Center for Devices and Radiological Health(CDRH), [2010-8-7]
    • U.S.Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research(CDER), Center for Biologics Evaluation and Research(CBER), Center for Devices and Radiological Health(CDRH), Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. [2010-8-7]. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.
    • Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims
  • 6
    • 79951989320 scopus 로고    scopus 로고
    • National Bureau of Statistics of China, May, (In Chinese)
    • National Bureau of Statistics of China, Bulletin of the 5th Population Census(NO. 1). May 2001. http://www.stats.gov.cn/tjgb/rkpcgb/qgrkpcgb/t20020331- 15434.htm (In Chinese).
    • (2001) Bulletin of the 5th Population Census , Issue.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.